CVRx, Inc.
NASDAQ:CVRX
14.17 (USD) • At close January 8, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | CVRx, Inc. |
Symbool | CVRX |
Munteenheid | USD |
Prijs | 14.17 |
Beurswaarde | 343,816,629 |
Dividendpercentage | 0% |
52-weken bereik | 6.4 - 29.23 |
Industrie | Medical Devices |
Sector | Healthcare |
CEO | Mr. Nadim Yared |
Website | https://www.cvrx.com |
An error occurred while fetching data.
Over CVRx, Inc.
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)